Research article · 8 Jul 2019
Case reportPublished 2016
Levamisole Induced Autoimmunity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Abstract Background: We present the case of a patient with vitiligo that was treated with levamisol and presented with pure levamisole induced vasculopathy. The patient had no cocaine use and immunologic findings persisted for more than 4 years after the consumption of the drug. Case Presentation: 70 year-old women with a history relevant for vitiligo. Shortly after initiating levamisole she developed extensive necrotic skin lesions, coagulopathy and thrombocytopenia. At the time she presented an hemorragic stroke that resulted in hemiparesia. Four months later, she presented with loss of consciousness and a mixed aphasia. A CT scan revealed the prior lesion only, an EEG showed abnormal activity. Her lab tests showed a positive lupus anticoagulant and p-ANCA. She was initially managed with phenytoin, levetiracetam and enoxaparin. She returned with a status epilepticus and was then managed with phenyotin, levetiracetam, and diazepam with no response. Considering a nonthrombotic manifestation of antiphospholipid syndrome methylprednisolone 1 gr per day for three doses were administered with improvement in language and motor function. She continued enoxaparin and prednisone with good results. Mycophenolate mofetil was later added to her treatment as a prednisone sparing agent. Lupus anticoagulant persists positive to this date. Conclusions: Vasculopathy presenting as skin necrosis or purpura is a feature of both cocaine and levamisole use. There are very few cases of levamisole only induced vasculitis and even less in the adult population. It is conventionally believed that the sole therapeutic intervention needed is avoidance of levamisol exposure. In this case, the persistence of lupus anticoagulant for more than 4 years, the neurologic symptoms upon steroid suspension and immediate response to bolus led to the decision of maintenance immunosupresive therapy and anticoagulation. There is a subset of patients who may develop an autoimmune disease and should be observed and treated for longer periods.
Subjects
OrthopaedicsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Case report · 2017
Oropharyngeal Dysphagia: Rare Presenting Symptom of Statin-induced HMG CoA Reductase Necrotizing Autoimmune Myopathy
Conference abstract · 13 Aug 2012
Therapeutic roles of TGF-�-induced regulatory T cells in the established autoimmune and inflammatory diseases
Case report · 2 Apr 2024
Autoimmune-Like Drug-Induced Liver Injury caused by Fenofibrate, Atorvastatin and Ezetimibe: A Case Report
Article · Mar 2016
Levamisole induced Vasculopathy: A Case of Extensive Necrosis after Re-exposure to Levamisole Tainted Cocaine
More from this journal
The newest in Journal of Arthritis.
Article · 12 Mar 2024
Outcome of the Treatment of Symptomatic Osteoarthritis of the Trapeziometacarpal Joint with an Oral Compound Containing Hyaluronic Acid, Chondroitin Sulfate, Hydrolyzed Collagen Type II, and Hydrolyzed Keratin in 40 Patients
Article · 18 Jan 2024
Investigating the Microrheological Properties of Knee Synovial Fluid by Means of the Multiple Tracking Technique
Article · 30 Sep 2023
Ankylosing spondylitis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Arthritis
- SubjectOrthopaedics
- BylineArticles whose byline prints “Nina Tello”
- BylineArticles whose byline prints “Jorge Alejandro Mateos-Parra”
- BylineArticles whose byline prints “Alejandro Díaz-Borjon”

